NIH and Exothera in partnership to produce COVID-19 vaccine
The new vaccine is an alternative to injected versions and no medical training is needed to deliver it
Read More
Tag: exothera
- Samsung Bioepis signs partnership with Sandoz for next‑generation biosimilars
- Atrogi begins dosing first subjects in human trial of ATR-258
- R1 Therapeutics launches with $77.5m to advance hyperphosphatemia treatment
- Taiwan Bio partners with Terumo to advance automated Treg manufacturing
- Elevara begins phase 2b trial of ELV001 in rheumatoid arthritis
